Personal tools

MCL coexpression mm9:2219: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004177!8.37e-14!29;UBERON:0005057!8.37e-14!29;UBERON:0002370!1.51e-12!23;UBERON:0000974!1.51e-12!23;UBERON:0004807!1.51e-12!23;UBERON:0005058!1.51e-12!23;UBERON:0003351!1.51e-12!23;UBERON:0009113!1.51e-12!23;UBERON:0003295!1.51e-12!23;UBERON:0009722!1.51e-12!23;UBERON:0005562!1.51e-12!23;UBERON:0007690!1.51e-12!23;UBERON:0000064!6.27e-12!99;UBERON:0006562!1.20e-11!24;UBERON:0003408!1.20e-11!24;UBERON:0001557!1.20e-11!24;UBERON:0001042!1.20e-11!24;UBERON:0008814!1.20e-11!24;UBERON:0009145!1.20e-11!24;UBERON:0000077!8.49e-11!35;UBERON:0000153!1.14e-10!43;UBERON:0007811!1.80e-09!36;UBERON:0000072!2.18e-09!27;UBERON:0002390!2.78e-09!45;UBERON:0003061!2.78e-09!45;UBERON:0003528!2.86e-09!29;UBERON:0002791!2.86e-09!29;UBERON:0001893!2.86e-09!29;UBERON:0002021!3.19e-09!10;UBERON:0000411!3.19e-09!10;UBERON:0001950!3.19e-09!10;UBERON:0002193!5.39e-09!48;UBERON:0002405!5.39e-09!48;UBERON:0002020!5.67e-09!34;UBERON:0003080!9.48e-09!40;UBERON:0002780!2.31e-08!39;UBERON:0001890!2.31e-08!39;UBERON:0006240!2.31e-08!39;UBERON:0001049!4.58e-08!52;UBERON:0005068!4.58e-08!52;UBERON:0006241!4.58e-08!52;UBERON:0007135!4.58e-08!52;UBERON:0000955!4.95e-08!47;UBERON:0006238!4.95e-08!47;UBERON:0000956!5.04e-08!21;UBERON:0001869!5.04e-08!21;UBERON:0000203!5.04e-08!21;UBERON:0003056!8.61e-08!49;UBERON:0000073!9.51e-08!54;UBERON:0002616!1.33e-07!46;UBERON:0002619!1.88e-07!17;UBERON:0010371!6.15e-07!73;UBERON:0000063!8.55e-07!35
|ontology_enrichment_uberon=UBERON:0004177!8.37e-14!29;UBERON:0005057!8.37e-14!29;UBERON:0002370!1.51e-12!23;UBERON:0000974!1.51e-12!23;UBERON:0004807!1.51e-12!23;UBERON:0005058!1.51e-12!23;UBERON:0003351!1.51e-12!23;UBERON:0009113!1.51e-12!23;UBERON:0003295!1.51e-12!23;UBERON:0009722!1.51e-12!23;UBERON:0005562!1.51e-12!23;UBERON:0007690!1.51e-12!23;UBERON:0000064!6.27e-12!99;UBERON:0006562!1.20e-11!24;UBERON:0003408!1.20e-11!24;UBERON:0001557!1.20e-11!24;UBERON:0001042!1.20e-11!24;UBERON:0008814!1.20e-11!24;UBERON:0009145!1.20e-11!24;UBERON:0000077!8.49e-11!35;UBERON:0000153!1.14e-10!43;UBERON:0007811!1.80e-09!36;UBERON:0000072!2.18e-09!27;UBERON:0002390!2.78e-09!45;UBERON:0003061!2.78e-09!45;UBERON:0003528!2.86e-09!29;UBERON:0002791!2.86e-09!29;UBERON:0001893!2.86e-09!29;UBERON:0002021!3.19e-09!10;UBERON:0000411!3.19e-09!10;UBERON:0001950!3.19e-09!10;UBERON:0002193!5.39e-09!48;UBERON:0002405!5.39e-09!48;UBERON:0002020!5.67e-09!34;UBERON:0003080!9.48e-09!40;UBERON:0002780!2.31e-08!39;UBERON:0001890!2.31e-08!39;UBERON:0006240!2.31e-08!39;UBERON:0001049!4.58e-08!52;UBERON:0005068!4.58e-08!52;UBERON:0006241!4.58e-08!52;UBERON:0007135!4.58e-08!52;UBERON:0000955!4.95e-08!47;UBERON:0006238!4.95e-08!47;UBERON:0000956!5.04e-08!21;UBERON:0001869!5.04e-08!21;UBERON:0000203!5.04e-08!21;UBERON:0003056!8.61e-08!49;UBERON:0000073!9.51e-08!54;UBERON:0002616!1.33e-07!46;UBERON:0002619!1.88e-07!17;UBERON:0010371!6.15e-07!73;UBERON:0000063!8.55e-07!35
|tfbs_overrepresentation_for_novel_motifs=0.641384,1.30284,0.612053,0.688265,1.21364,0.704257,0.803568,0.370124,0.381467,0.162942,0.755749,0.790506,1.72258,0.81685,0.502646,0,1.02248,0.473993,0.928768,0.683591,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,1.32554,0.290745,0.711848,1.12823,0.471365,0.854272,0.503207,0.30022,1.16474,0.786577,0.434783,1.03515,0.478558,0.717547,0.185353,0.504971,1.10847,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.771943,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.98374,2.48198,1.32691,1.55806,0.310084,0.318792,0.926147,1.08947,1.40903,0.37865,1.04072,0.884013,0.362446,1.20828,6.45377,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.367176,1.14445,0.938512,0.731844,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,1.42067,1.4032,0.633483,1.25851,1.41174,0.7614,1.51002,0.476467,3.46168,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,0.569254,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.79777,1.63788,1.27621,1.069,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,1.52606,0.993294,0.830321,0.459159,0.788782,2.03331
}}
}}

Revision as of 21:05, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr17:51952537..51952552,-p15@Satb1
Mm9::chr17:51972332..51972342,+p@chr17:51972332..51972342
+
Mm9::chr17:51972345..51972362,+p@chr17:51972345..51972362
+
Mm9::chr18:39679035..39679049,-p@chr18:39679035..39679049
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0016571histone methylation0.0162712978688435
GO:0005720nuclear heterochromatin0.0162712978688435
GO:0008213protein amino acid alkylation0.0162712978688435
GO:0006479protein amino acid methylation0.0162712978688435
GO:0000790nuclear chromatin0.0162712978688435
GO:0016570histone modification0.0162712978688435
GO:0000792heterochromatin0.0162712978688435
GO:0016569covalent chromatin modification0.0162712978688435
GO:0043414biopolymer methylation0.0162712978688435
GO:0032259methylation0.0162712978688435
GO:0044454nuclear chromosome part0.0216950638251246
GO:0006730one-carbon compound metabolic process0.0216950638251246
GO:0000228nuclear chromosome0.0216950638251246
GO:0016568chromatin modification0.0426153039422091
GO:0000785chromatin0.0465238590916562



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
hemopoietic organ8.37e-1429
immune organ8.37e-1429
thymus1.51e-1223
neck1.51e-1223
respiratory system epithelium1.51e-1223
hemolymphoid system gland1.51e-1223
pharyngeal epithelium1.51e-1223
thymic region1.51e-1223
pharyngeal gland1.51e-1223
entire pharyngeal arch endoderm1.51e-1223
thymus primordium1.51e-1223
early pharyngeal endoderm1.51e-1223
organ part6.27e-1299
pharynx1.20e-1124
gland of gut1.20e-1124
upper respiratory tract1.20e-1124
chordate pharynx1.20e-1124
pharyngeal arch system1.20e-1124
pharyngeal region of foregut1.20e-1124
mixed endoderm/mesoderm-derived structure8.49e-1135
anterior region of body1.14e-1043
craniocervical region1.80e-0936
segment of respiratory tract2.18e-0927
hematopoietic system2.78e-0945
blood island2.78e-0945
brain grey matter2.86e-0929
regional part of telencephalon2.86e-0929
telencephalon2.86e-0929
occipital lobe3.19e-0910
visual cortex3.19e-0910
neocortex3.19e-0910
hemolymphoid system5.39e-0948
immune system5.39e-0948
gray matter5.67e-0934
anterior neural tube9.48e-0940
regional part of forebrain2.31e-0839
forebrain2.31e-0839
future forebrain2.31e-0839
neural tube4.58e-0852
neural rod4.58e-0852
future spinal cord4.58e-0852
neural keel4.58e-0852
brain4.95e-0847
future brain4.95e-0847
cerebral cortex5.04e-0821
cerebral hemisphere5.04e-0821
pallium5.04e-0821
pre-chordal neural plate8.61e-0849
regional part of nervous system9.51e-0854
regional part of brain1.33e-0746
regional part of cerebral cortex1.88e-0717
ecto-epithelium6.15e-0773
organ segment8.55e-0735


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}